Cell line · CVCL_0159
B16-F10
Cancer cell line, Mus musculus. Mouse melanoma. 239 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. B16-F10. Cell lines, record CVCL_0159. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0159
On this page
Cell line
As Cellosaurus gives it.
- Name
- B16-F10
- Accession
- CVCL_0159
- RRID
- RRID:CVCL_0159
- Synonyms
- B16/F10, B16 F10, B16F10, B16 melanoma F10
- Species
- Mus musculus (Mouse)
- Sex
- Male
- Age at sampling
- Age unspecified
- Category
- Cancer cell line
- Diseases
- Mouse melanoma (NCIt C21790)
- Derived from
- Skin (in situ)
- Parent
- B16-F5 (CVCL_UJ41)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers239
12 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| PubMed 43000531 | Nat Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Isolation, Structural Elucidation, and Anti-Melanogenic Activity of a Novel Pectic Polysaccharide From Alhagi camelorum Fisch. | Chem Biodivers | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Double coordination-driven Fe-DOX synergy enhances ferroptosis and immunogenic cancer therapy. | Acta Pharm Sin B | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Ruthenium(II) Carbosilane Dendrimers With Aliphatic Polyamine Ligands for In Vivo Antimelanoma Activity. | Bioinorg Chem Appl | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Compartment-specific PPARδ activity controls the outcome of cancer-immune cell competition and immunotherapy efficacy. | Nat Immunol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| On-demand design of controlled-release systems using an expert-mimic AI framework. | Nat Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Focal therapeutic conditions matter: How energy affects antigen presentation and T cell activation. | Bioeng Transl Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Protective Effects of Duchesnea chrysantha Ethanol Extract Against UVB-Induced Skin Damage via Modulation of TAK1-Associated Signaling Pathways. | Chem Biodivers | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Deep Learning-Based Quantification of Spontaneous Pain Behaviours in Mice. | Eur J Pain | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Intravenously deliverable oncolytic virus VET3-TGI favorably alters the tumor microenvironment. | J Immunother Cancer | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 239
See all 239 papersRelatives67
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Parent | B16-F5 | CVCL_UJ41 | Cell lines | |
| Derived from it | B16-BL6 | CVCL_0157 | Cell lines | |
| Derived from it | B16-F10 B2m-KO | CVCL_D0P3 | Cell lines | |
| Derived from it | B16-F10 Pbrm1 KO 1 | CVCL_E3VN | Cell lines | |
| Derived from it | B16-F10 Pbrm1 KO 2 | CVCL_E3VP | Cell lines | |
| Derived from it | B16-F10-EGFP | CVCL_XB96 | Cell lines | |
| Derived from it | B16-F10-Lr6 | CVCL_U240 | Cell lines | |
| Derived from it | B16-F10-Luc | CVCL_C8XU | Cell lines | |
| Derived from it | B16-F10-Luc 1-#3 | CVCL_4Y00 | Cell lines | |
| Derived from it | B16-F10-Luc2 [ATCC] | CVCL_A4CJ | Cell lines |
1 to 10 of 67
See all 67 relativesCell banks14
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CRL-6475 | ATCC | |
| AddexBio | C0012005/5003 | Cellosaurus | |
| BCRC | 60031 | BCRC | |
| BCRJ | 0046 | BCRJ | |
| CLS | 305157 | CLS | |
| Hysigen | TCM-C713 | Hysigen | |
| ICLC | ATL99010 | ICLC | |
| KCB | KCB 2014047YJ | Cellosaurus | |
| KCLB | 80008 | KCLB | |
| NCBI_Iran | C540 | Cellosaurus |
1 to 10 of 14
See all 14 cell banksData dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0159
GET https://conductscience.org/api/cell-lines/v1/CVCL_0159/papers?page=2